In Dec. 2017, the U.S. Food and Drug Administration (FDA) acknowledged how gadolinium, a metal often found in magnetic resonance imaging (MRI) contrast dye, can be detrimental to a patient's heath. The federal agency's realization led them to recommend that radiologists better educate patients about the dangers of using this substance and use alternatives.
Patients worry about many things when taking prescription medications, including whether they'll suffer adverse side effects and whether it will be subject to a recall. Many patients suffer unexpected outcomes from taking prescription drugs that their doctors prescribe, yet most recalls don't happen until several adverse events occur.
The U.S. Food and Drug Administration (FDA) recalled several Valsartan blood pressure medications from the market in 2019 due to their potential contamination with carcinogenic contaminates N-nitrosodiethylamine (NDEA) and N-nitrosodimethylamine (NDMA). Many of these prescription drugs had been on the market for as long as four years when the federal agency discovered the potentially dangerous nitrosamine compound contamination. Medical analysts now looking back on the recall argue that it posed minimal risk to patients.
Risperdal is a drug that has pros and cons. It is sometimes used to treat severe behavior problems in children. For example, it may be used to treat Attention-Deficit Hyperactivity Disorder (ADHD) or autism if the children are aggressive or highly irritable. It can be used for psychosis as well.
Recalls happen for items such as food products, toys and cars all the time. Medical device or drug recalls for medications are quite common as well. Perhaps even more surprising is that vaccines can even be recalled due to there being a bad lot or batch.
The path for prescription drugs to get approved and introduced on the market here in the United States is a multi-level process. Its manufacturer must generally get the preliminary go-ahead from the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) before they can move forward with the critical testing stage. Some drugs get fast-tracked though thus bypassing stringent analysis of it though.
The U.S. Food and Drug Administration (FDA) issued a recall of a popularly prescribed weight loss medication last week. The federal agency did so after discovering that lorcaserin, a drug that is more commonly known by its brand name Belviq, may put patients who take it at a higher risk for developing cancer.
TDF, or tenofovir disoproxil fumarate, is a drug designed to treat human immunodeficiency virus (HIV). Marketed by Gilead under the brand name Truvada (along with others), TDF drugs were seen as a first-line treatment for HIV.
Tenofovir disoproxil fumarite (TDF) drugs designed to treat the Human Immunodeficiency Virus (HIV) are marketed under a variety of names, including Truvada, Atripla, Viread. They've been a longstanding component of successful HIV treatment for many years for many people afflicted with this potentially deadly disease.
The U.S. Food and Drug Administration (FDA) issued a public warning to those who take the over-the-counter heartburn drug Zantac on Sept. 13. They announced that the same carcinogen that identified in prescription blood pressure medications earlier this year was also found in Zantac pills.